NIAID Banner Logo Image


1. 45390 HIV-LS-324; PUBMED-HIV-6/13/2005

Anti-HIV Activity of (-)-(2R,4R)-1- (2-Hydroxymethyl-1,3-dioxolan-4-yl)- thymine against Drug-Resistant HIV-1 Mutants and Studies of Its Molecular Mechanism

Chu, CK, Yadav, V, Chong, YH, and Schinazi, RF

J Med Chem 2005. 48(12): 3949-52


2. 45391 HIV-LS-324; EMBASE-HIV-6/13/2005

Synthesis, biological activity and modelling studies of two novel anti HIV PR inhibitors with a thiophene containing hydroxyethylamino core

Bonini, Carlo, Chiummiento, Lucia, Bonis, Margherita De, Funicello, Maria, Lupattelli, Paolo, Suanno, Gerardina, Berti, Federico, and Campaner, Pietro

Tetrahedron 2005. 61(27): 6580-6589


3. 45392 HIV-LS-324; PUBMED-HIV-6/13/2005

Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection

Tapia, N, Fernandez, G, Parera, M, Gomez-Mariano, G, Clotet, B, Quinones-Mateu, M, Domingo, E, and Martinez, MA

Virology 2005.


4. 45393 HIV-LS-324; PUBMED-HIV-6/13/2005

Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)

Marozsan, AJ, Kuhmann, SE, Morgan, T, Herrera, C, Rivera-Troche, E, Xu, S, Baroudy, BM, Strizki, J, and Moore, JP

Virology 2005.


5. 45394 HIV-LS-324; PUBMED-HIV-6/13/2005

Two new chiral nucleoside analogues: (4R,5R)-4-(4,6-dimethylpyrimidin-2-ylsulfanyl)-5-[(2S,5R)-2-isopropyl-5-me thylcyclohexyloxy]-2,3,4,5-tetrahydrofuran-2-one and (4R,5R)-5-[(2S,5R)-isopropyl-5-methylcyclohexyloxy]-4-(4-methyl-1,3-thiazo l-2-ylamino)-2,3,4,5-tetrahydrofuran-2-one

He, L, Liu, YM, Zhang, W, and Chen, QH

Acta Crystallogr C 2005. 61(Pt 6): 390-2


6. 45395 HIV-LS-324; PUBMED-HIV-6/13/2005

Design, synthesis and bioactivities of TAR RNA targeting beta-carboline derivatives based on Tat-TAR interaction

Yu, X, Lin, W, Pang, R, and Yang, M

Eur J Med Chem 2005.


7. 45396 HIV-LS-324; PUBMED-HIV-6/13/2005

Design, synthesis, and biological evaluation of novel 4-hydroxypyrone derivatives as HIV-1 protease inhibitors

Sun, CL, Pang, RF, Zhang, H, and Yang, M

Bioorg Med Chem Lett 2005.


8. 45397 HIV-LS-324; PUBMED-HIV-6/13/2005

Bromophenols Coupled with Derivatives of Amino Acids and Nucleosides from the Red Alga Rhodomela confervoides

Zhao, J, Ma, M, Wang, S, Li, S, Cao, P, Yang, Y, Lu, Y, Shi, J, Xu, N, Fan, X, and He, L

J Nat Prod 2005. 68(5): 691-694


9. 45398 HIV-LS-324; PUBMED-HIV-6/13/2005

Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton

Zhong, Y, Yoshinaka, Y, Takeda, T, Shimizu, N, Yoshizaki, S, Inagaki, Y, Matsuda, S, Honda, G, Fujii, N, and Yamamoto, N

Antiviral Res 2005. 66(2-3): 119-28


10. 45399 HIV-LS-324; PUBMED-HIV-6/13/2005

Synthesis of new phorbol derivatives having ethereal side chain and evaluation of their anti-HIV activity

Matsuya, Y, Yu, Z, Yamamoto, N, Mori, M, Saito, H, Takeuchi, M, Ito, M, and Nemoto, H

Bioorg Med Chem 2005.


11. 45400 HIV-LS-324; PUBMED-HIV-6/13/2005

Lancifodilactone G: a unique nortriterpenoid isolated from Schisandra lancifolia and its anti-HIV activity

Xiao, WL, Zhu, HJ, Shen, YH, Li, RT, Li, SH, Sun, HD, Zheng, YT, Wang, RR, Lu, Y, Wang, C, and Zheng, QT

Org Lett 2005. 7(11): 2145-8


12. 45401 HIV-LS-324; PUBMED-HIV-6/13/2005

DNA aptamers as potential anti-HIV agents

Chou, SH, Chin, KH, and Wang, AH

Trends Biochem Sci 2005. 30(5): 231-4


13. 45402 HIV-LS-324; PUBMED-HIV-6/13/2005

Identification of Amino Acid Residues in the Human Immunodeficiency Virus Type-1 Reverse Transcriptase Tryptophan-repeat Motif that are Required for Subunit Interaction Using Infectious Virions

Mulky, A, Sarafianos, SG, Jia, Y, Arnold, E, and Kappes, JC

J Mol Biol 2005. 349(4): 673-84


14. 45403 HIV-LS-324; WOS-HIV-6/5/2005

Design and expression of a Trojan horse anti-HIV peptide

Barnes, DR, Nalivaika, EA, Schiffer, CA, and Osterhout, JJ

PROTEIN SCIENCE 2004. 13: 197-1


15. 45404 HIV-LS-324; WOS-HIV-6/5/2005

Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency

McGuigan, C, Harris, SA, Daluge, SM, Gudmundsson, KS, McLean, EW, Burnette, TC, Marr, H, Hazen, R, Condreay, LD, Johnson, L, De, Clercq E, and Balzarini, J

JOURNAL OF MEDICINAL CHEMISTRY 2005. 48(10): 3504-3515, 12


16. 45405 HIV-LS-324; WOS-HIV-6/5/2005

The fusion activity of HIV-1 gp41 depends on interhelical interactions

Suntoke, TR and Chan, DC

JOURNAL OF BIOLOGICAL CHEMISTRY 2005. 280(20): 19852-19857, 6


17. 45406 HIV-LS-324; WOS-HIV-6/5/2005

Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor

Perez, EE, Riley, JL, Carroll, RG, von Laer, D, and June, CH

CLINICAL IMMUNOLOGY 2005. 115(1): 26-32, 7


18. 45407 HIV-LS-324; WOS-HIV-6/12/2005

Natural resistance of human immunodeficiency virus type 2 to zidovudine

Reid, P, MacInnes, H, Cong, ME, Heneine, W, and Garcia-Lerma, JG

VIROLOGY 2005. 336(2): 251-264, 14


19. 45408 HIV-LS-324; WOS-HIV-6/12/2005

Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120

Wang, JS, Le, N, Heredia, A, Song, HJ, Redfield, R, and Wang, LX

ORGANIC & BIOMOLECULAR CHEMISTRY 2005. 3(9): 1781-1786, 6


20. 45409 HIV-LS-324; WOS-HIV-6/12/2005

Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A

Witvrouw, M, Fikkert, V, Hantson, A, Pannecouque, C, O'Keefe, BR, McMahon, J, Stamatatos, L, de, Clercq E, and Bolmstedt, A

JOURNAL OF VIROLOGY 2005. 79(12): 7777-7784, 8


21. 45410 HIV-LS-324; WOS-HIV-6/12/2005

Natural antibodies to CCR5 from breast milk block infection of macrophages and dendritic cells with primary R5-tropic HIV-1

Bouhlal, H, Latry, V, Requena, M, Aubry, S, Kaveri, SV, Kazatchkine, MA, Belec, L, and Hocini, H

JOURNAL OF IMMUNOLOGY 2005. 174(11): 7202-7209, 8


22. 45411 HIV-LS-324; WOS-HIV-6/12/2005

An old target revisited: Two new privileged skeletons and an unexpected binding mode for HIV-protease inhibitors

Specker, E, Bottcher, J, Lilie, H, Heine, A, Schoop, A, Muller, G, Griebenow, N, and Klebe, G



If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024